Loading
Enrique Espinosa is a medical oncologist working on melanoma and gene-expression biomarkers.
Enrique Espinosa is a medical oncologist at Hospital Universitario La Paz and Professor at the Universidad Autónoma de Madrid. His specialisms are melanoma, breast cancer and gene expression signatures, and his research covers melanoma treatment and prognostic gene-expression signatures in breast cancer and melanoma. He works within the Spanish Multidisciplinary Melanoma Group (GEM). His papers include the GEM-1402 phase II trial of nivolumab plus ipilimumab in treatment-naive metastatic uveal melanoma, a Nature Medicine phase 2 study of clinical and molecular response to tebentafusp in previously treated metastatic uveal melanoma, and a GEM review of predictive factors of response to immunotherapy. His publications are listed on PubMed.
| Title | Journal | Year |
|---|---|---|
| Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402) | Journal of Clinical Oncology | 2021 |
| Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial | Nature Medicine | 2022 |
| Predictive factors of response to immunotherapy—a review from the Spanish Melanoma Group (GEM) | Annals of Translational Medicine | 2017 |